Ledford, B. T., Wyatt, T. G., Vang, J., Weiss, J., Tsihlis, N. D., & Kibbe, M. R. (2023). Effects of Particle Size, Charge, Shape, Animal Disease State, and Sex on the Biodistribution of Intravenously Administered Nanoparticles. PARTICLE & PARTICLE SYSTEMS CHARACTERIZATION, 40(7). doi:10.1002/ppsc.202300001

Ledford, B. T., Akerman, A. W., Sun, K., Gillis, D. C., Weiss, J. M., Vang, J., . . . Kibbe, M. R. (2022). Peptide Amphiphile Supramolecular Nanofibers Designed to Target Abdominal Aortic Aneurysms. ACS NANO, 16(5), 7309-7322. doi:10.1021/acsnano.1c06258

Peters, E. B., Karver, M. R., Sun, K., Gillis, D. C., Biswas, S., Clemons, T. D., . . . Kibbe, M. R. (2021). Self-Assembled Peptide Amphiphile Nanofibers for Controlled Therapeutic Delivery to the Atherosclerotic Niche. ADVANCED THERAPEUTICS, 4(9). doi:10.1002/adtp.202100103

Marulanda, K., Mercel, A., Gillis, D. C., Sun, K., Gambarian, M., Roark, J., . . . Kibbe, M. R. (2021). Intravenous Delivery of Lung-Targeted Nanofibers for Pulmonary Hypertension in Mice. ADVANCED HEALTHCARE MATERIALS, 10(13). doi:10.1002/adhm.202100302

Mercel, A. I., Marulanda, K., Gillis, D. C., Sun, K., Clemons, T. D., Willcox, S., . . . Kibbe, M. R. (2021). Development of novel nanofibers targeted to smoke-injured lungs. BIOMATERIALS, 274. doi:10.1016/j.biomaterials.2021.120862

Yu, L., Newton, E. R., Gillis, D. C., Sun, K., Cooley, B. C., Keith, A. N., . . . Kibbe, M. R. (2021). Coating small-diameter ePTFE vascular grafts with tunable poly(diol-co-citrate-co-ascorbate) elastomers to reduce neointimal hyperplasia. BIOMATERIALS SCIENCE, 9(15), 5160-+. doi:10.1039/d1bm00101a

Newton, E. R., Gillis, D. C., Sun, K., Dandurand, B. R., Siletzky, R., Biswas, S., . . . Kibbe, M. R. (2021). Evaluation of a Targeted Drug-Eluting Intravascular Nanotherapy to Prevent Neointimal Hyperplasia in an Atherosclerotic Rat Model. ADVANCED NANOBIOMED RESEARCH, 1(7). doi:10.1002/anbr.202000093

Kassam, H. A., Bahnson, E. M., Cartaya, A., Jiang, W., Avram, M. J., Tsihlis, N. D., . . . Kibbe, M. R. (2020). Pharmacokinetics and biodistribution of a collagen-targeted peptide amphiphile for cardiovascular applications. PHARMACOLOGY RESEARCH & PERSPECTIVES, 8(6). doi:10.1002/prp2.672

Marulanda, K., Tsihlis, N. D., McLean, S. E., & Kibbe, M. R. (2021). Emerging antenatal therapies for congenital diaphragmatic hernia-induced pulmonary hypertension in preclinical models. PEDIATRIC RESEARCH, 89(7), 1641-1649. doi:10.1038/s41390-020-01191-x

Mercel, A. I., Gillis, D. C., Sun, K., Dandurand, B. R., Weiss, J. M., Tsihlis, N. D., . . . Kibbe, M. R. (2020). A comparative study of a preclinical survival model of smoke inhalation injury in mice and rats. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 319(3), L471-L480. doi:10.1152/ajplung.00241.2020

Klein, M. K., Kassam, H. A., Lee, R. H., Bergmeier, W., Peters, E. B., Gillis, D. C., . . . Kibbe, M. R. (2020). Development of Optimized Tissue-Factor-Targeted Peptide Amphiphile Nanofibers to Slow Noncompressible Torso Hemorrhage. ACS NANO, 14(6), 6649-6662. doi:10.1021/acsnano.9b09243

Mercel, A., Tsihlis, N. D., Maile, R., & Kibbe, M. R. (2020). Emerging therapies for smoke inhalation injury: a review. JOURNAL OF TRANSLATIONAL MEDICINE, 18(1). doi:10.1186/s12967-020-02300-4

Yu, L., He, W., Peters, E. B., Ledford, B. T., Tsihlis, N. D., & Kibbe, M. R. (2020). Development of Poly(1,8-octanediol-co-citrate-co-ascorbate) Elastomers with Enhanced Ascorbate Performance for Use as a Graft Coating to Prevent Neointimal Hyperplasia. ACS APPLIED BIO MATERIALS, 3(4), 2150-2159. doi:10.1021/acsabm.0c00019

Kassam, H. A., Gillis, D. C., Dandurand, B. R., Karver, M. R., Tsihlis, N. D., Stupp, S. I., & Kibbe, M. R. (2020). Development of Fractalkine-Targeted Nanofibers that Localize to Sites of Arterial Injury. NANOMATERIALS, 10(3). doi:10.3390/nano10030420

Klein, M. K., Tsihlis, N. D., Pritts, T. A., & Kibbe, M. R. (2020). Emerging Therapies for Prehospital Control of Hemorrhage. JOURNAL OF SURGICAL RESEARCH, 248, 182-190. doi:10.1016/j.jss.2019.09.070

Mansukhani, N. A., Peters, E. B., So, M. M., Albaghdadi, M. S., Wang, Z., Karver, M. R., . . . Kibbe, M. R. (2019). Peptide Amphiphile Supramolecular Nanostructures as a Targeted Therapy for Atherosclerosis. MACROMOLECULAR BIOSCIENCE, 19(6). doi:10.1002/mabi.201900066

Peters, E. B., Tsihlis, N. D., Karver, M. R., Chin, S. M., Musetti, B., Ledford, B. T., . . . Kibbe, M. R. (2019). Atheroma Niche-Responsive Nanocarriers for Immunotherapeutic Delivery. ADVANCED HEALTHCARE MATERIALS, 8(3). doi:10.1002/adhm.201801545

Morgan, C. E., Dombrowski, A. W., Perez, C. M. R., Bahnson, E. S. M., Tsihlis, N. D., Jiang, W., . . . Kibbe, M. R. (2018). Tissue-Factor Targeted Peptide Amphiphile Nanofibers as an Injectable Therapy To Control Hemorrhage (vol 10, pg 899, 2016). ACS NANO, 12(11), 11711. doi:10.1021/acsnano.8b07028

Tsihlis, N. D., Rodriguez, M. P., Jiang, Q., Schwartz, A., Flynn, M. E., Vercammen, J. M., & Kibbe, M. R. (2016). Nitric oxide differentially affects proteasome activator 28 after arterial injury in type 1 and type 2 diabetic rats. JOURNAL OF SURGICAL RESEARCH, 202(2), 413-421. doi:10.1016/j.jss.2016.01.030

Morgan, C. E., Dombrowski, A. W., Perez, C. M. R., Bahnson, E. S. M., Tsihlis, N. D., Jiang, W., . . . Kibbe, M. R. (2016). Tissue-Factor Targeted Peptide Amphiphile Nanofibers as an Injectable Therapy To Control Hemorrhage. ACS NANO, 10(1), 899-909. doi:10.1021/acsnano.5b06025

Rodriguez, M. P., Tsihlis, N. D., Emond, Z. M., Wang, Z., Varu, V. N., Jiang, Q., . . . Kibbe, M. R. (2015). Nitric oxide affects UbcH10 levels differently in type 1 and type 2 diabetic rats. JOURNAL OF SURGICAL RESEARCH, 196(1), 180-189. doi:10.1016/j.jss.2015.02.012

Tsihlis, N. D., Vavra, A. K., Martinez, J., Lee, V. R., & Kibbe, M. R. (2013). Nitric oxide is less effective at inhibiting neointimal hyperplasia in spontaneously hypertensive rats. NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 35, 165-174. doi:10.1016/j.niox.2013.10.005

Tsihlis, N. D., Kapadia, M. R., Vavra, A. K., Flannery, W. D., Oustwani, C. S., Jiang, Q., & Kibbe, M. R. (2013). Nitric oxide may inhibit neointimal hyperplasia by decreasing isopeptidase T levels and activity in the vasculature. JOURNAL OF VASCULAR SURGERY, 58(1), 179-186. doi:10.1016/j.jvs.2012.10.066

Havelka, G. E., Moreira, E. S., Rodriguez, M. P., Tsihlis, N. D., Wang, Z., Martinez, J., . . . Kibbe, M. R. (2013). Nitric Oxide Delivery via a Permeable Balloon Catheter Inhibits Neointimal Growth after Arterial Injury (vol 180, pg 35, 2013). JOURNAL OF SURGICAL RESEARCH, 183(2), 984. doi:10.1016/j.jss.2013.03.056

Havelka, G. E., Moreira, E. S., Rodriguez, M. P., Tsihlis, N. D., Wang, Z., Martinez, J., . . . Kibbe, M. R. (2013). Nitric oxide delivery via a permeable balloon catheter inhibits neointimal growth after arterial injury. JOURNAL OF SURGICAL RESEARCH, 180(1), 35-42. doi:10.1016/j.jss.2012.10.048

Tsihlis, N. D., Kapadia, M. R., Vavra, A. K., Jiang, Q., Fu, B., Martinez, J., & Kibbe, M. R. (2012). Nitric oxide decreases activity and levels of the 11S proteasome activator PA28 in the vasculature. NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 27(1), 50-58. doi:10.1016/j.niox.2012.04.006

Tsihlis, N. D., Murar, J., Kapadia, M. R., Ahanchi, S. S., Oustwani, C. S., Saavedra, J. E., . . . Kibbe, M. R. (2010). Isopropylamine NONOate (IPA/NO) moderates neointimal hyperplasia following vascular injury. JOURNAL OF VASCULAR SURGERY, 51(5), 1248-1259. doi:10.1016/j.jvs.2009.12.028